N 6-methyladenosine (m 6 A), as the most pervasive internal modification of eukaryotic
mRNA, plays a crucial role in various cancers, but its role in multiple myeloma (MM) …

Abstract RNA N6-methyladenosine (m6A) is an emerging regulator of mRNA modifications
and represents a novel player in tumorigenesis. Although it has functional significance in …

Abstract Aims N6-Methyladenosine (m 6 A) is the most frequent posttranscriptional
modification and plays important roles in tumorigenesis and metastasis. The roles of fat …

Abstract N6-methyladenosine (m6A) acts as the most common mRNA modification in
mammal cells. Fat Mass and Obesity-associated protein (FTO) is the firstly identified …

Abstract N 6-Methyladenosine (m6A) is the most abundant modification of mammalian
mRNAs. RNA methylation fine tunes RNA stability and translation, altering cell fate. The fat …

Background Epitranscriptomics studies have contributed greatly to the development of
research on human cancers. In recent years, N6-methyladenosine (m6A), an RNA …

Melanoma is one of the most deadly and therapy-resistant cancers. Here we show that N6-
methyladenosine (m6A) mRNA demethylation by fat mass and obesity-associated protein …

Multiple myeloma (MM) is still incurable partially due to lacking effective therapeutic targets.
Aberrant N6-methyladenosine (m6A) RNA modification plays a vital role in many cancers …

In 2007, the fat mass and obesity-associated (FTO) gene was discovered initially to regulate
body mass index and obesity and was subsequently found to be the first mRNA N6 …

Pancreatic cancer (PC) is one of the most fatal cancers with a very poor prognosis. Here, we
found that N6-methyladenosine (m6A) RNA demethylase fat mass and obesity-related …